TRDA, a technology-based company, is scheduled to report its quarterly earnings on May 11. Analysts are expecting a significant rise in earnings, with estimates pointing to a 20% increase, bringing earnings per share (EPS) to -63 cents. The last earnings report on December 31 showed better-than-expected results, with earnings per share of -79 cents, beating the estimate of -83 cents. In this article, we will dive into TRDA's financial ratios and technical indicators to analyze its potential performance after the earnings release.
Sign up for one of these top-performing robots today and start earning more profits in no time!
Key Financial Ratios
Price-to-Book (P/B) Ratio: TRDA's P/B ratio of 1.903 is in line with the industry mean of 23.555, suggesting that the stock is fairly valued relative to its peers.
Price-to-Earnings (P/E) Ratio: The company's P/E ratio of 0.000 is within average values for comparable stocks (124.876), indicating that it is not overpriced based on its earnings.
Projected Growth (PEG Ratio): TRDA's PEG ratio of 0.000 is also within normal values, averaging 3.848, suggesting that the stock's growth prospects are in line with industry standards.
Dividend Yield: The company's dividend yield of 0.000 is around the average of 0.029 among similar stocks, which means that investors can expect a reasonable return on their investment.
Price-to-Sales (P/S) Ratio: TRDA's P/S ratio of 0.000 is also within normal values, averaging 317.511, which implies that the stock is not overvalued based on its sales.
Market Capitalization
With 39.57K shares outstanding, TRDA's current market capitalization sits at $384.64 million. This figure indicates that the company has a reasonable market size, and it has the potential to generate higher revenues in the future.
Technical Analysis
TRDA's 10-day Relative Strength Index (RSI) Indicator recently moved out of the overbought zone on April 18, 2023. This development could signal a shift from an upward trend to a downward trend. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor analyzed 6 instances where the RSI indicator left the overbought zone, and in all cases, the stock moved lower in the days that followed. This puts the odds of a move down at 90%.
Although TRDA's financial ratios are within average values, the recent RSI indicator movement suggests that the stock might experience a downward trend in the short term. Investors should closely monitor the company's earnings release on May 11 and consider their investment strategy accordingly. While the company has demonstrated growth in its last earnings report, the technical indicators point towards potential challenges in the near future.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
TRDA saw its Momentum Indicator move below the 0 level on September 15, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 88 similar instances where the indicator turned negative. In 81 of the 88 cases, the stock moved further down in the following days. The odds of a decline are at 90%.
TRDA moved below its 50-day moving average on September 15, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for TRDA crossed bearishly below the 50-day moving average on September 18, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 16 of 18 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 89%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where TRDA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 85%.
The Aroon Indicator for TRDA entered a downward trend on October 16, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +2.09% 3-day Advance, the price is estimated to grow further. Considering data from situations where TRDA advanced for three days, in 261 of 305 cases, the price rose further within the following month. The odds of a continued upward trend are 86%.
TRDA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron Valuation Rating of 63 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.038) is normal, around the industry mean (26.782). P/E Ratio (10.259) is within average values for comparable stocks, (43.395). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (0.000) among similar stocks. P/S Ratio (61.350) is also within normal values, averaging (437.542).
The Tickeron Price Growth Rating for this company is 89 (best 1 - 100 worst), indicating slightly worse than average price growth. TRDA’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 92 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TRDA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry Biotechnology